Rephonic
Artwork for BioCentury This Week

BioCentury This Week

BioCentury
FDA
China
Biotech
Biotechnology
Clinical Trials
Biosecure Act
Obesity
Biotech Industry
Mergers and Acquisitions
Drug Development
Alzheimer's Disease
Gene Therapy
FDA Regulations
Novo Nordisk
Inflation Reduction Act
Biotech Innovation
Pediatric Priority Review Vouchers
Biopharma
Grand Rounds
Psychedelics

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

PublishesTwice weeklyEpisodes379Founded6 years ago
Number of ListenersCategories
Life SciencesScienceBusiness

Listen to this Podcast

Artwork for BioCentury This Week

Latest Episodes

Revolution Medicines continues to impress with more pancreatic cancer data, earning a standing ovation at ASCO over the weekend. On the latest BioCentury This Week podcast, BioCentury’s analysts discuss the detailed data for the company’s daraxonrasi... more

YouTube

At ASCO among presentations focused on pancreatic cancer innovation beyond KRAS; however, abstracts for the cancer conference also highlight ADCs, bispecifics and diagnostics that are broadening the field’s approach to the cancer. On the latest BioCe... more

YouTube

Marty Makary wasn’t the only official on the outs at FDA last week in another tumultuous turn of events for the regulatory agency. On the latest BioCentury This Week podcast, BioCentury Washington Editor Steve Usdin discusses who’s in, who’s out and ... more

YouTube

China’s speed in generating first-in-human data has catalyzed a race across the globe to reshape regulatory requirements to compete. BioCentury’s analysts, along with special guests Detlev Mennerich, head of Boehringer Ingelheim Venture Fund, and Meh... more

YouTube

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more

Recent Guests

Josh Berlin
Head of BD at BioCentury
BioCentury
Episode: Ep. 369 - ASCO advances, China innovation & U.S. science under threat
Richard Pops
CEO, Alkermes (former)
Alkermes
Episode: Ep. 369 - ASCO advances, China innovation & U.S. science under threat
Tierney Baum
Bio Pharma Analyst
BioCentury
Episode: Ep. 368 - ASCO Preview, China Policy, ADC Linkers
Richard Pazdur
Director emeritus of the FDA Oncology Center of Excellence, noted regulator discussed in fireside chat
FDA
Episode: Ep. 366 - Europe's need for speed: Bio€quity takeaways
Karen Tkach-Tuzman
Colleague and neighbor, Grand Rounds organizer
BioCentury
Episode: Ep. 364 - UCB’s Candid buy, Grand Rounds and leukodystrophies
Danielle Gollivan
Senior Bio Pharma analyst
BioCentury
Episode: Ep. 364 - UCB’s Candid buy, Grand Rounds and leukodystrophies
James Kyle Bryan
CMO of IQVIA Biotech
IQVIA Biotech
Episode: Ep. 362 - AACR: Data and de-risking
Simone Fishburne
Editor-in-Chief
BioCentury
Episode: Ep. 360 - FDA’s FIH plans. Plus: billion-dollar deals, funds
Steve Ustin
Washington Editor
BioCentury
Episode: Ep. 360 - FDA’s FIH plans. Plus: billion-dollar deals, funds

Hosts

Jeff Cranmer
Host of BioCentury This Week Podcast, BioCentury lead editor with broad coverage of biopharma policy, deals and strategy.
Simone Fishburne
Editor-in-Chief, BioCentury; regular contributor and policy/trends commentator.
Steve Usdin
Washington editor; provides regulatory and policy context for biotech investing and PDUFA discussions.

Reviews

4.7 out of 5 stars from 79 ratings
  • terrific summaries capturing the news in this fast-moving space

    LOVE this weekly look at what is happening in biotech, both deep dives into the science itself plus the regulatory/legislative challenges and more. All the regulars are deeply knowledgeable and Jeff Cranmer’s levity as host makes the pod enjoyable and digestible--you really do feel like you have a seat at their editorial meetings. GREAT recaps of the news and in ~30 min or less, I look forward to listening each week!

    Apple Podcasts
    5
    Ios9 problem
    United States2 years ago
  • Great insights and wisdom!

    Awesome helps me and my team navigate efficiently

    Apple Podcasts
    5
    Surfrider182
    United States2 years ago
  • Simone Fishburn!!!!

    Simone Fishburn is so well spoken and such a tremendous host. Need more of her in our lives !!

    Apple Podcasts
    5
    Pretty Kitty 2
    United States6 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Guests are described as highly knowledgeable and the show as offering strong editorial leadership with credible experts.
Listeners praise concise, data-driven coverage that covers both science and policy in an accessible way.
The host's ability to translate complex regulatory changes into actionable business implications is often highlighted.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Ep. 368 - ASCO Preview, China Policy, ADC Linkers
Q: What are the main arguments for and against a more protectionist stance toward China in biotech deals?
Proponents argue that protecting sensitive biotechnologies is essential to national security and long-term leadership, citing high-profile deals as examples; opponents warn that protectionism can curb collaboration, slow innovation, and raise costs, emphasizing that many global science advances require cross-border partnerships.
Ep. 368 - ASCO Preview, China Policy, ADC Linkers
Q: Can you talk a little bit about what the reforms entail, Steve?
The reforms center on embedding clinical trials into routine healthcare delivery, creating a network of trial platforms, with FDA CDER steering coordination, ARPA-H supporting pilots, and NIH driving multiple platform pilots to advance faster, safer, and more efficient early-stage trials.
Ep. 365 - Thin ice for Makary, redosing AAVs
Q: What is the latest on Makary's position and the political dynamics around the FDA leadership?
The hosts discuss reporting that Makary is on thin ice, the role of HHS and the White House in guiding leadership, and the likelihood that an acting commissioner will be appointed with potential internal candidates.
Ep. 362 - AACR: Data and de-risking
Q: Kyle, how are you thinking about ASCO from where you sit at this time of year?
ASCO is a pull-through from AACR and will likely feature more on dual payload ADCs, with early clinical proofs and ongoing discussion of resistance origins. We expect phase one expansion data to be watched, and the data may shape clinical practice discussions while signaling trends for 2027 ASCO.
Ep. 357 - Deal-O-rama, Gilead and Tallon's U.K. vision
Q: What did you learn from the Tallon interview about the UK's new clinical trial reforms?
Tallon's overview highlighted accelerated timelines, a 14-day first assessment window, a notifiable scheme for low-risk trials, a 150-day overall target from application to first patient dosing, and a concerted effort to align MHRA with NICE through the Aligned Pathway to speed approvals and unlock broader European market access.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About BioCentury This Week

What is BioCentury This Week about and what kind of topics does it cover?

Biotech industry insiders, investors, and policy watchers tune into a succinct weekly briefing on deal activity, regulatory shifts, and scientific advances shaping biopharma. Episodes repeatedly stitch together data from ASCO, FDA regulatory developments, and European regulatory dynamics with real-world implications for R&D timing, funding, and market access. The show stands out for its editor-driven framing, tight 30-minute format, and a roster of deep-domain guests who illuminate the interplay between science, policy, and dealmaking. Listeners likely appreciate practical takeaways—what data signals mean for pipelines, partnerships, and go-to-market timelines—and the show's ability to translate complex developments into actionable context ... more

Where can I find podcast stats for BioCentury This Week?

Rephonic provides a wide range of podcast stats for BioCentury This Week. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to BioCentury This Week and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does BioCentury This Week get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for BioCentury This Week, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for BioCentury This Week?

Rephonic provides comprehensive predictive audience data for BioCentury This Week, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does BioCentury This Week have?

To see how many followers or subscribers BioCentury This Week has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to BioCentury This Week?

These podcasts share a similar audience with BioCentury This Week:

1. Biotech Hangout
2. The Readout Loud
3. The Long Run with Luke Timmerman
4. The BioCentury Show
5. Business Of Biotech

How many episodes of BioCentury This Week are there?

BioCentury This Week launched 6 years ago and published 379 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact BioCentury This Week?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for BioCentury This Week?

Rephonic pulls ratings and reviews for BioCentury This Week from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for BioCentury This Week?

Rephonic provides full transcripts for episodes of BioCentury This Week. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on BioCentury This Week?

Recent guests on BioCentury This Week include:

1. Josh Berlin
2. Richard Pops
3. Tierney Baum
4. Richard Pazdur
5. Karen Tkach-Tuzman
6. Danielle Gollivan
7. James Kyle Bryan
8. Simone Fishburne

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days